07.11.2022 - Results show strong signals of clinical responses in patients with advanced cervical cancer who received up to 2 prior lines of therapyOSLO, Norway, Nov. 07, 2022 (GLOBE NEWSWIRE) - Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage ... Seite 1